Nextstellis approved for Thailand in partnership with Fuji Pharma.
Announcement by Mithra.
Tokyo - Fuji Pharma Co., Ltd. (Tokyo Stock Exchange: 4554, 'Fuji') and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA, 'Mithra') today are pleased to announce that OLIC (Thailand) Limited ('OLIC'), a subsidiary of Fuji, has obtained the approval of import license for NEXTSTELLIS, a novel combination contraceptive containing estetrol and drospirenone, for the indication of Contraception.
OLIC anticipates the commercial launch of NEXTSTELLIS contraceptive pill in Thailand by the end of 2023.
Another Nextstellis Mention, page-138
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.48 |
Change
0.070(1.59%) |
Mkt cap ! $381.1M | |||
| Open | High | Low | Value | Volume |
| $4.43 | $4.54 | $4.42 | $1.026M | 230.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 154 | $4.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.50 | 16238 | 2 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |